Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03205046 |
Title | A Study of Acalabrutinib and Vistusertib in Subjects With Relapsed/Refractory B-cell Malignancies |
Recruitment | Terminated |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Acerta Pharma BV |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | GBR |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Research Site | Fairway | Kansas | 66205 | United States | Details | |
Research Site | Bethesda | Maryland | 20892 | United States | Details | |
Research Site | Rochester | Minnesota | 55902 | United States | Details | |
Research Site | Omaha | Nebraska | 68198 | United States | Details | |
Research Site | Hackensack | New Jersey | 07601 | United States | Details | |
Research Site | Nashville | Tennessee | 37203 | United States | Details | |
Research Site | Seattle | Washington | 98109 | United States | Details | |
Research Site | Headington | OX3 7LJ | United Kingdom | Details | ||
Research Site | London | EC1A 7BE | United Kingdom | Details | ||
Research Site | Nottingham | NG5 1PB | United Kingdom | Details | ||
Research Site | Sutton | SM2 5PT | United Kingdom | Details |